TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.
A new South Georgia clinic offers minimally invasive specialty care locally, so patients don't have to drive hours to Atlanta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results